chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: RECEIVED SECOND DOSE OF PFIZER 1/6/21 MILD SYMPTOMS OF COVID-19 STARTED 1/22/2021 LASTED APPROX 10 DAYS (RUNNY NOSE, CONGESTION), POSITIVE PCR 1/31/21 RECEIVED BOOSTER PFIZER 10/8/21 MODERATE SYMPTOMS OF COVID-19 AND POSITIVE PCR 1/3/2022; COUGH, SORE THROAT, CONGESTION, HEADACHE STILL ONGOING AS OF 1/7/2022; MISSED WORK, SAW DOCTOR AND RECEIVED ALBUTEROL INHALER RX, NOT HOSPITALIZED
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Cough, Diarrhoea, Fatigue
Clinical narrative: NIGHT SWEATS, VOMITING, LOOSE STOOLS, COUGH, FATIGUE, LOSS OF TASTE AND SMELL, NASAL DRAINAGE
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Night sweats, Rhinorrhoea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: NIGHT SWEATS, VOMITING, LOOSE STOOLS, COUGH, FATIGUE, LOSS OF TASTE AND SMELL, NASAL DRAINAGE
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Arthropathy, Joint noise, X-ray limb normal
Clinical narrative: Since the Covid vaccination, the shoulder frequently "Freezes" and has to be held and supported to "Click" back into place.  The "Cracking" can be heard and felt by anyone when I, the patient", moves the shoulder.   When I went to see my physician, a shoulder series of x-rays were taken and showed no arthritic changes.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: My menstrual period arrived 2 days early, on 12/23/21. It was not due until 12/25/21. I continued to experience menstrual bleeding for 12 days, with my last day of bleeding 1/3/22. My typical period lasts only 3 days. I sent a message to my doctor on 1/3/22 to ask if I should be concerned about the extended bleeding and was reassured that I should not be concerned at this time.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness
Clinical narrative: PASSING OUT
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Condition aggravated, Heart rate increased, Oxygen saturation decreased
Clinical narrative: Chills, rapid heart rate in the 130. Low Oxygen saturation level was 91. Drank lots of fluids and rested.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Lower respiratory tract infection, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: Woman on the phone told me to fill out a report because of the symptoms i was having.   I had what appeared to be a chest cold.  My doctor prescribes ZPACK due to me be Fully Vaccinated and i had a negative antigen and PCR test for covid 19.   After taking all prescribed medication, i then tested POSITVE on an antigen test and then Positive on a PCR test, a full week later.  Symptoms now have subsided, however i tested positive on an antigen test again today 1/7/22
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Client reported they were 12 years olf when they were only 11. Adult dose of Pfizer was given incorrectly.
Age: 43.0
Sex: M
Vaccine: TDAP
Symptoms: Chills, Fatigue, Full blood count normal, Headache, Metabolic function test normal
Clinical narrative: fever of 101-1028*F, chills, fatigue, headache, arm pain, and underarm swelling.
Age: 43.0
Sex: M
Vaccine: TDAP
Symptoms: Oedema peripheral, Pain in extremity, Pyrexia
Clinical narrative: fever of 101-1028*F, chills, fatigue, headache, arm pain, and underarm swelling.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Asthenia, Blood glucose decreased, Blood test, COVID-19
Clinical narrative: Hospitalized 1/2/2022; COVID-19 positive 1/2/2022; fully vaccinated Admission Date: 1/2/2022 Admitting Diagnoses: AKI Discharge Date: 1/6/2022 Details of Hospital Stay PRESENTING PROBLEM: Acute on chronic kidney failure    HOSPITAL COURSE: Patient is a 68 year old male with PMH of type 2 diabetes, hyperlipidemia, HFpEF, essential hypertension, and obesity. He presented with cough, generalized weakness, fatigue, and poor appetite. He was found to have COVID pneumonia and is fully vaccinated. Patient never became hypoxic and was not started on steroids. He was found to have an AKI on CKD3 likely due to his poor oral intake. He has been started on IVF and his kidney function slowly returned to baseline. The patient also started to feel better overall and his PO intake started to increase. His kidney function was close to baseline at time of discharge. His lasix was restarted day of discharge as the patient was slightly fluid positive. His lisinopril was held at discharge and the patient should follow up with his PCP early next week for repeat blood work to determine the appropriateness of restarting medication. The patient was up titrated on hydralazine to help control his blood pressure in its absence. The patient should weigh himself daily and call his PCP sooner if his weight increases more then 5lbs.  In regards to COVID-19 the patient remained asymptomatic and CXR was clear from infiltrates. As patient symptoms were more then 2 weeks ago he no longer needs to quarantine. Patient did have some low blood sugars while inpatient thought to be secondary to over medication of insulin. The patient was instructed to closely monitor his blood sugar at home and make adjustments if necessary. The patient was hemodynamically stable at time of discharge
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray normal, Chronic kidney disease, Condition aggravated, Cough
Clinical narrative: Hospitalized 1/2/2022; COVID-19 positive 1/2/2022; fully vaccinated Admission Date: 1/2/2022 Admitting Diagnoses: AKI Discharge Date: 1/6/2022 Details of Hospital Stay PRESENTING PROBLEM: Acute on chronic kidney failure    HOSPITAL COURSE: Patient is a 68 year old male with PMH of type 2 diabetes, hyperlipidemia, HFpEF, essential hypertension, and obesity. He presented with cough, generalized weakness, fatigue, and poor appetite. He was found to have COVID pneumonia and is fully vaccinated. Patient never became hypoxic and was not started on steroids. He was found to have an AKI on CKD3 likely due to his poor oral intake. He has been started on IVF and his kidney function slowly returned to baseline. The patient also started to feel better overall and his PO intake started to increase. His kidney function was close to baseline at time of discharge. His lasix was restarted day of discharge as the patient was slightly fluid positive. His lisinopril was held at discharge and the patient should follow up with his PCP early next week for repeat blood work to determine the appropriateness of restarting medication. The patient was up titrated on hydralazine to help control his blood pressure in its absence. The patient should weigh himself daily and call his PCP sooner if his weight increases more then 5lbs.  In regards to COVID-19 the patient remained asymptomatic and CXR was clear from infiltrates. As patient symptoms were more then 2 weeks ago he no longer needs to quarantine. Patient did have some low blood sugars while inpatient thought to be secondary to over medication of insulin. The patient was instructed to closely monitor his blood sugar at home and make adjustments if necessary. The patient was hemodynamically stable at time of discharge
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Decreased appetite, Fatigue, Fluid balance positive, Hypophagia, Overdose
Clinical narrative: Hospitalized 1/2/2022; COVID-19 positive 1/2/2022; fully vaccinated Admission Date: 1/2/2022 Admitting Diagnoses: AKI Discharge Date: 1/6/2022 Details of Hospital Stay PRESENTING PROBLEM: Acute on chronic kidney failure    HOSPITAL COURSE: Patient is a 68 year old male with PMH of type 2 diabetes, hyperlipidemia, HFpEF, essential hypertension, and obesity. He presented with cough, generalized weakness, fatigue, and poor appetite. He was found to have COVID pneumonia and is fully vaccinated. Patient never became hypoxic and was not started on steroids. He was found to have an AKI on CKD3 likely due to his poor oral intake. He has been started on IVF and his kidney function slowly returned to baseline. The patient also started to feel better overall and his PO intake started to increase. His kidney function was close to baseline at time of discharge. His lasix was restarted day of discharge as the patient was slightly fluid positive. His lisinopril was held at discharge and the patient should follow up with his PCP early next week for repeat blood work to determine the appropriateness of restarting medication. The patient was up titrated on hydralazine to help control his blood pressure in its absence. The patient should weigh himself daily and call his PCP sooner if his weight increases more then 5lbs.  In regards to COVID-19 the patient remained asymptomatic and CXR was clear from infiltrates. As patient symptoms were more then 2 weeks ago he no longer needs to quarantine. Patient did have some low blood sugars while inpatient thought to be secondary to over medication of insulin. The patient was instructed to closely monitor his blood sugar at home and make adjustments if necessary. The patient was hemodynamically stable at time of discharge
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Renal impairment, SARS-CoV-2 test positive
Clinical narrative: Hospitalized 1/2/2022; COVID-19 positive 1/2/2022; fully vaccinated Admission Date: 1/2/2022 Admitting Diagnoses: AKI Discharge Date: 1/6/2022 Details of Hospital Stay PRESENTING PROBLEM: Acute on chronic kidney failure    HOSPITAL COURSE: Patient is a 68 year old male with PMH of type 2 diabetes, hyperlipidemia, HFpEF, essential hypertension, and obesity. He presented with cough, generalized weakness, fatigue, and poor appetite. He was found to have COVID pneumonia and is fully vaccinated. Patient never became hypoxic and was not started on steroids. He was found to have an AKI on CKD3 likely due to his poor oral intake. He has been started on IVF and his kidney function slowly returned to baseline. The patient also started to feel better overall and his PO intake started to increase. His kidney function was close to baseline at time of discharge. His lasix was restarted day of discharge as the patient was slightly fluid positive. His lisinopril was held at discharge and the patient should follow up with his PCP early next week for repeat blood work to determine the appropriateness of restarting medication. The patient was up titrated on hydralazine to help control his blood pressure in its absence. The patient should weigh himself daily and call his PCP sooner if his weight increases more then 5lbs.  In regards to COVID-19 the patient remained asymptomatic and CXR was clear from infiltrates. As patient symptoms were more then 2 weeks ago he no longer needs to quarantine. Patient did have some low blood sugars while inpatient thought to be secondary to over medication of insulin. The patient was instructed to closely monitor his blood sugar at home and make adjustments if necessary. The patient was hemodynamically stable at time of discharge
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Blood test, Computerised tomogram, Hepatic enzyme increased, Magnetic resonance imaging
Clinical narrative: Severe pain in stomach and to back the resulted in ER visit and hospital admission on 12/23 due to Pancreatitis and elevated liver enzymes. Dr stated tests show no other info and felt it could be a virus settled in pancreas and could not state if vaccine did or did not cause it.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pancreatitis, Scan with contrast
Clinical narrative: Severe pain in stomach and to back the resulted in ER visit and hospital admission on 12/23 due to Pancreatitis and elevated liver enzymes. Dr stated tests show no other info and felt it could be a virus settled in pancreas and could not state if vaccine did or did not cause it.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of the internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Breast feeding, Chest pain, Computerised tomogram thorax normal, Contraception, Fibrin D dimer increased
Clinical narrative: I began my menses for the second time for the month of December which is not normal for me and it lasted 20 days. It continued to last 20 days every month for three months until I was finally seen by my OBGYN Dr. and my thyroid and labs were ok, my pelvic physical exam was also okay and my ultrasound of my pelvis was okay. I was started back on birth control to control the bleeding and the next month it only lasted 3 days as it normally did before the vaccines for COVID. I received the fist Pfizer dose at 8pm around the start of my night shift and when I awoke during the day around 2pm was found to have started my menses for the second time that month. I was also breastfeeding my baby still so have wondered how this effected her.  I also begin to have pain around my left chest when breathing and went to the ER in hospital probably within a month of completing the vaccines. My D-dimer was elevated so I was sent for a CT of the chest but they didn't find any PE's.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Gynaecological examination, Heavy menstrual bleeding, Laboratory test normal, Menstrual disorder, Polymenorrhoea
Clinical narrative: I began my menses for the second time for the month of December which is not normal for me and it lasted 20 days. It continued to last 20 days every month for three months until I was finally seen by my OBGYN Dr. and my thyroid and labs were ok, my pelvic physical exam was also okay and my ultrasound of my pelvis was okay. I was started back on birth control to control the bleeding and the next month it only lasted 3 days as it normally did before the vaccines for COVID. I received the fist Pfizer dose at 8pm around the start of my night shift and when I awoke during the day around 2pm was found to have started my menses for the second time that month. I was also breastfeeding my baby still so have wondered how this effected her.  I also begin to have pain around my left chest when breathing and went to the ER in hospital probably within a month of completing the vaccines. My D-dimer was elevated so I was sent for a CT of the chest but they didn't find any PE's.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Thyroid function test normal, Ultrasound pelvis normal
Clinical narrative: I began my menses for the second time for the month of December which is not normal for me and it lasted 20 days. It continued to last 20 days every month for three months until I was finally seen by my OBGYN Dr. and my thyroid and labs were ok, my pelvic physical exam was also okay and my ultrasound of my pelvis was okay. I was started back on birth control to control the bleeding and the next month it only lasted 3 days as it normally did before the vaccines for COVID. I received the fist Pfizer dose at 8pm around the start of my night shift and when I awoke during the day around 2pm was found to have started my menses for the second time that month. I was also breastfeeding my baby still so have wondered how this effected her.  I also begin to have pain around my left chest when breathing and went to the ER in hospital probably within a month of completing the vaccines. My D-dimer was elevated so I was sent for a CT of the chest but they didn't find any PE's.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Erythema, Induration, Injection site erythema, Nodule
Clinical narrative: 24 hrs post administration, developed 5cm round hard subcutaneous nodule.  Warm and tender to touch. Started self treatment with Benadryl 50mg HS, used "anti-itch" cream (Benadryl generic) to 5cm area, and ice packs. 48 hrs post administration, developed erythema from anterior right shoulder to elbow, posterior shoulder, right chest.  Had severe itching. but avoided scratching.  Developed two 1-2cm vesicles.  Continued Benadryl 50 mg HS, topical Benadryl cream, ice packs. 72 hrs post administration erythema decreased slightly. 96 hrs post administration erythema markedly decreased, itching decreased, injection site measures 15cm.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin warm, Tenderness
Clinical narrative: 24 hrs post administration, developed 5cm round hard subcutaneous nodule.  Warm and tender to touch. Started self treatment with Benadryl 50mg HS, used "anti-itch" cream (Benadryl generic) to 5cm area, and ice packs. 48 hrs post administration, developed erythema from anterior right shoulder to elbow, posterior shoulder, right chest.  Had severe itching. but avoided scratching.  Developed two 1-2cm vesicles.  Continued Benadryl 50 mg HS, topical Benadryl cream, ice packs. 72 hrs post administration erythema decreased slightly. 96 hrs post administration erythema markedly decreased, itching decreased, injection site measures 15cm.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Nasal congestion, SARS-CoV-2 test positive
Clinical narrative: NASAL CONGESTION POST COVID EXPOSURE
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: Guillen-Barre Syndrome
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Ageusia, Anosmia, Anticoagulant therapy, Anticoagulation drug level above therapeutic
Clinical narrative: Patient discharged after 3 days hospitalization. Patient is a 61 y.o. male presented with shortness of breath on exertion along with cold sweats, cough, right-sided chest pain, worsened when taking a deep breaths. Patient also had diarrhea, loss of taste and smell. He was vaccinated against with Pfizer but did not receive booster dose. Workup in the emergency department significant for sodium 127 and creatinine 2.42 (previous 1.7). X-ray showing COVID pneumonia and patient had wheezing. Patient was admitted for acute kidney injury, COVID pneumonia. AKI resolved with IV fluids. Due to elevated procalcitonin, patient was started on IV ceftriaxone and oral doxycycline and was transitioned to oral Ceftin and Doxy for total 5 days of treatment. Due to AKI, lisinopril, Lasix and Aldactone were held. Due to history of low EF, Lasix was resumed at discharge after AKI is resolved. Patient was advised to monitor blood pressure and blood sugar levels closely at home and follow up with PCP. Due to low blood sugars, Lantus dose was decreased. Patient is on warfarin for A. Fib and was supratherapeutic with INR. Patient was advised to hold warfarin and check INR at home and follow up with anticoagulation clinic for further recommendations regarding warfarin dosing. Patient was discharged to Home without services in stable condition.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Bacterial test negative, Blood creatinine increased, Blood culture negative, Blood glucose decreased
Clinical narrative: Patient discharged after 3 days hospitalization. Patient is a 61 y.o. male presented with shortness of breath on exertion along with cold sweats, cough, right-sided chest pain, worsened when taking a deep breaths. Patient also had diarrhea, loss of taste and smell. He was vaccinated against with Pfizer but did not receive booster dose. Workup in the emergency department significant for sodium 127 and creatinine 2.42 (previous 1.7). X-ray showing COVID pneumonia and patient had wheezing. Patient was admitted for acute kidney injury, COVID pneumonia. AKI resolved with IV fluids. Due to elevated procalcitonin, patient was started on IV ceftriaxone and oral doxycycline and was transitioned to oral Ceftin and Doxy for total 5 days of treatment. Due to AKI, lisinopril, Lasix and Aldactone were held. Due to history of low EF, Lasix was resumed at discharge after AKI is resolved. Patient was advised to monitor blood pressure and blood sugar levels closely at home and follow up with PCP. Due to low blood sugars, Lantus dose was decreased. Patient is on warfarin for A. Fib and was supratherapeutic with INR. Patient was advised to hold warfarin and check INR at home and follow up with anticoagulation clinic for further recommendations regarding warfarin dosing. Patient was discharged to Home without services in stable condition.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium decreased, COVID-19, COVID-19 pneumonia, Cardiomegaly, Chest X-ray abnormal
Clinical narrative: Patient discharged after 3 days hospitalization. Patient is a 61 y.o. male presented with shortness of breath on exertion along with cold sweats, cough, right-sided chest pain, worsened when taking a deep breaths. Patient also had diarrhea, loss of taste and smell. He was vaccinated against with Pfizer but did not receive booster dose. Workup in the emergency department significant for sodium 127 and creatinine 2.42 (previous 1.7). X-ray showing COVID pneumonia and patient had wheezing. Patient was admitted for acute kidney injury, COVID pneumonia. AKI resolved with IV fluids. Due to elevated procalcitonin, patient was started on IV ceftriaxone and oral doxycycline and was transitioned to oral Ceftin and Doxy for total 5 days of treatment. Due to AKI, lisinopril, Lasix and Aldactone were held. Due to history of low EF, Lasix was resumed at discharge after AKI is resolved. Patient was advised to monitor blood pressure and blood sugar levels closely at home and follow up with PCP. Due to low blood sugars, Lantus dose was decreased. Patient is on warfarin for A. Fib and was supratherapeutic with INR. Patient was advised to hold warfarin and check INR at home and follow up with anticoagulation clinic for further recommendations regarding warfarin dosing. Patient was discharged to Home without services in stable condition.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Cold sweat, Cough, Diarrhoea, Dyspnoea
Clinical narrative: Patient discharged after 3 days hospitalization. Patient is a 61 y.o. male presented with shortness of breath on exertion along with cold sweats, cough, right-sided chest pain, worsened when taking a deep breaths. Patient also had diarrhea, loss of taste and smell. He was vaccinated against with Pfizer but did not receive booster dose. Workup in the emergency department significant for sodium 127 and creatinine 2.42 (previous 1.7). X-ray showing COVID pneumonia and patient had wheezing. Patient was admitted for acute kidney injury, COVID pneumonia. AKI resolved with IV fluids. Due to elevated procalcitonin, patient was started on IV ceftriaxone and oral doxycycline and was transitioned to oral Ceftin and Doxy for total 5 days of treatment. Due to AKI, lisinopril, Lasix and Aldactone were held. Due to history of low EF, Lasix was resumed at discharge after AKI is resolved. Patient was advised to monitor blood pressure and blood sugar levels closely at home and follow up with PCP. Due to low blood sugars, Lantus dose was decreased. Patient is on warfarin for A. Fib and was supratherapeutic with INR. Patient was advised to hold warfarin and check INR at home and follow up with anticoagulation clinic for further recommendations regarding warfarin dosing. Patient was discharged to Home without services in stable condition.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea exertional, Influenza A virus test, Influenza B virus test, Joint space narrowing, Legionella test
Clinical narrative: Patient discharged after 3 days hospitalization. Patient is a 61 y.o. male presented with shortness of breath on exertion along with cold sweats, cough, right-sided chest pain, worsened when taking a deep breaths. Patient also had diarrhea, loss of taste and smell. He was vaccinated against with Pfizer but did not receive booster dose. Workup in the emergency department significant for sodium 127 and creatinine 2.42 (previous 1.7). X-ray showing COVID pneumonia and patient had wheezing. Patient was admitted for acute kidney injury, COVID pneumonia. AKI resolved with IV fluids. Due to elevated procalcitonin, patient was started on IV ceftriaxone and oral doxycycline and was transitioned to oral Ceftin and Doxy for total 5 days of treatment. Due to AKI, lisinopril, Lasix and Aldactone were held. Due to history of low EF, Lasix was resumed at discharge after AKI is resolved. Patient was advised to monitor blood pressure and blood sugar levels closely at home and follow up with PCP. Due to low blood sugars, Lantus dose was decreased. Patient is on warfarin for A. Fib and was supratherapeutic with INR. Patient was advised to hold warfarin and check INR at home and follow up with anticoagulation clinic for further recommendations regarding warfarin dosing. Patient was discharged to Home without services in stable condition.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Lung hyperinflation, Lung opacity, Musculoskeletal chest pain, Osteoarthritis, Pain
Clinical narrative: Patient discharged after 3 days hospitalization. Patient is a 61 y.o. male presented with shortness of breath on exertion along with cold sweats, cough, right-sided chest pain, worsened when taking a deep breaths. Patient also had diarrhea, loss of taste and smell. He was vaccinated against with Pfizer but did not receive booster dose. Workup in the emergency department significant for sodium 127 and creatinine 2.42 (previous 1.7). X-ray showing COVID pneumonia and patient had wheezing. Patient was admitted for acute kidney injury, COVID pneumonia. AKI resolved with IV fluids. Due to elevated procalcitonin, patient was started on IV ceftriaxone and oral doxycycline and was transitioned to oral Ceftin and Doxy for total 5 days of treatment. Due to AKI, lisinopril, Lasix and Aldactone were held. Due to history of low EF, Lasix was resumed at discharge after AKI is resolved. Patient was advised to monitor blood pressure and blood sugar levels closely at home and follow up with PCP. Due to low blood sugars, Lantus dose was decreased. Patient is on warfarin for A. Fib and was supratherapeutic with INR. Patient was advised to hold warfarin and check INR at home and follow up with anticoagulation clinic for further recommendations regarding warfarin dosing. Patient was discharged to Home without services in stable condition.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Painful respiration, Procalcitonin increased, Respiratory syncytial virus test, SARS-CoV-2 test positive, Spinal osteoarthritis
Clinical narrative: Patient discharged after 3 days hospitalization. Patient is a 61 y.o. male presented with shortness of breath on exertion along with cold sweats, cough, right-sided chest pain, worsened when taking a deep breaths. Patient also had diarrhea, loss of taste and smell. He was vaccinated against with Pfizer but did not receive booster dose. Workup in the emergency department significant for sodium 127 and creatinine 2.42 (previous 1.7). X-ray showing COVID pneumonia and patient had wheezing. Patient was admitted for acute kidney injury, COVID pneumonia. AKI resolved with IV fluids. Due to elevated procalcitonin, patient was started on IV ceftriaxone and oral doxycycline and was transitioned to oral Ceftin and Doxy for total 5 days of treatment. Due to AKI, lisinopril, Lasix and Aldactone were held. Due to history of low EF, Lasix was resumed at discharge after AKI is resolved. Patient was advised to monitor blood pressure and blood sugar levels closely at home and follow up with PCP. Due to low blood sugars, Lantus dose was decreased. Patient is on warfarin for A. Fib and was supratherapeutic with INR. Patient was advised to hold warfarin and check INR at home and follow up with anticoagulation clinic for further recommendations regarding warfarin dosing. Patient was discharged to Home without services in stable condition.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Streptococcus test negative, Superinfection, Urine analysis normal, Viral test, Wheezing
Clinical narrative: Patient discharged after 3 days hospitalization. Patient is a 61 y.o. male presented with shortness of breath on exertion along with cold sweats, cough, right-sided chest pain, worsened when taking a deep breaths. Patient also had diarrhea, loss of taste and smell. He was vaccinated against with Pfizer but did not receive booster dose. Workup in the emergency department significant for sodium 127 and creatinine 2.42 (previous 1.7). X-ray showing COVID pneumonia and patient had wheezing. Patient was admitted for acute kidney injury, COVID pneumonia. AKI resolved with IV fluids. Due to elevated procalcitonin, patient was started on IV ceftriaxone and oral doxycycline and was transitioned to oral Ceftin and Doxy for total 5 days of treatment. Due to AKI, lisinopril, Lasix and Aldactone were held. Due to history of low EF, Lasix was resumed at discharge after AKI is resolved. Patient was advised to monitor blood pressure and blood sugar levels closely at home and follow up with PCP. Due to low blood sugars, Lantus dose was decreased. Patient is on warfarin for A. Fib and was supratherapeutic with INR. Patient was advised to hold warfarin and check INR at home and follow up with anticoagulation clinic for further recommendations regarding warfarin dosing. Patient was discharged to Home without services in stable condition.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Underdose
Clinical narrative: Covid #1 given on 2/15/2021, #2 on 3/15/2021 and boosted on 10/31/2021.  Boosted was with 0.25 mL and not 0.5, which would have been more appropriate for an immunocompromised patient.   Booster dose given at Pharmacy.  Patient admitted to hospital on 12/30/2021 and expired on 1/6/2022 Tested positive for Covid-19 on admission
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient completed Pfizer primary series in June 2021.  Received booster vaccine with Moderna today.  At this time, patient is experiencing no adverse reactions.    Parent and patient both wanted the patient to receive a Moderna booster and were aware of the EUA covering for 18+ years of age, but still pressed through with the vaccine error only identified after administration.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Immediate post-injection reaction, Paraesthesia
Clinical narrative: pt got the pfizer vaccine dose 3 .  she immediately experienced tingling and numbness in her left foot. i called her 48 hours later and she was still experiencing the tingling/numbness
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test normal, Ultrasound scan
Clinical narrative: My lymph nodes near my clavicle on my left side have been extremely swollen for almost three months. I am also experiencing extreme fatigue. I have had multiple doctor's visits, bloodwork, and an ultrasound because of it.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: During a review of the  Department of Health?s internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Muscle twitching, Pain in extremity
Clinical narrative: Since vaccination has had pain in shoulder, down arm and twitching in tricep
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given 0.5ml instead of 0.25ml
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Generalized severe urticaria - upper body mainly
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Client presented to clinic for second dose of Moderna COVID-19 vaccine. Administered 0.25 ml booster dose instead of 0.5 ml full dose. After administration error was identified and while client was still in clinic she was notified of the error. After consulting nurse manager, a second 0.25 ml dose of Moderna COVID-19 vaccine was administered.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dysphagia, Feeding disorder, Gingival swelling, Inflammation
Clinical narrative: I got my booster shot and had normal symptoms that Friday and Saturday nights. But Sunday morning, I felt swelling in my tonsils. I had difficulty swallowing and going down the esophagus, I had pain in my chest when eating because my throat as well. The next day, my gums were swelling and eating was so uncomfortable. I called my PCP and went in for an exam on 01/06/2022 and my doctor informed me the booster shot triggered an inflammatory response and caused all of the inflammation and swelling in my digestive system. I was given Valacyclovir and Omeprazole to help reduce the inflammation. I also got a COVID-19 PCR test and awaiting my results on that.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Throat irritation, Tonsillar hypertrophy
Clinical narrative: I got my booster shot and had normal symptoms that Friday and Saturday nights. But Sunday morning, I felt swelling in my tonsils. I had difficulty swallowing and going down the esophagus, I had pain in my chest when eating because my throat as well. The next day, my gums were swelling and eating was so uncomfortable. I called my PCP and went in for an exam on 01/06/2022 and my doctor informed me the booster shot triggered an inflammatory response and caused all of the inflammation and swelling in my digestive system. I was given Valacyclovir and Omeprazole to help reduce the inflammation. I also got a COVID-19 PCR test and awaiting my results on that.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Respiratory tract congestion
Clinical narrative: Respiratory Congestion. Recurring cough since day after second injection.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Pain, Renal pain
Clinical narrative: Right kidney pain, body aches, injection site erythema
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, Swelling face
Clinical narrative: Patient c/o face tingling.  Face swelled significantly.  He ended up in the ER.  He received Iv steroids and Benadryl.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Vaccine Administration Error- Patient wanted a Moderna Booster (previously received Janssen as her primary series), however received a Pfizer Booster instead. Patient was understanding and did not seem to have any adverse effect.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac flutter, Chest discomfort, Chest pain, Inflammation, Myocarditis
Clinical narrative: Since vaccine, likely mild myocarditis (suspected from pcp as well).  2 cases of potential flutter, a few cases of chest pain but more tightness and feeling of inflamed heart.  Has been getting better and subsided for the most part .  I have been exercising extensively after booster so that may have aggravated that too.  Although during exercise and after, no issues.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given  0.5ml instead of 0.25ml
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Blood immunoglobulin E, Laboratory test, Pruritus, Type IV hypersensitivity reaction
Clinical narrative: Approximately 3 weeks post vaccine I started experiences itching scalp and random hives all over my body. The hives have continued for three weeks and appear daily throught the day. OTC antihistimines such as Zyrtech and Benedryl provide some relief but they still apear. Visited an allergiest yesterday and pending allergy testing. The physician felt strongly that this could potentially be a delayed reaction to the booster vaccine but again other labs are still pending. The allergist is Dr. in city, state.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Approximately 3 weeks post vaccine I started experiences itching scalp and random hives all over my body. The hives have continued for three weeks and appear daily throught the day. OTC antihistimines such as Zyrtech and Benedryl provide some relief but they still apear. Visited an allergiest yesterday and pending allergy testing. The physician felt strongly that this could potentially be a delayed reaction to the booster vaccine but again other labs are still pending. The allergist is Dr. in city, state.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: HOSPITALIZATION WITH COVID-19 BREAKTHROUGH CASE 1/5/22 - ongoing
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: positive covid test in fully vaccinated pt
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given 0.5ml instead of 0.25ml
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Pt received moderna vaccines on 02/03/2021 and 03/03/2021. Pt presented to the ED with complaints of SOB. pt was found tobe COVID positive.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cold sweat, Cough, Diarrhoea, Dyspnoea, Headache
Clinical narrative: cough, sore throat, cold sweats, congestion, shortness of breath due to coughing, headache, body aches, taste is off, smell is off, nausea, diarrhea.  starting 1/1/22
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Oropharyngeal pain, Pain, Parosmia, Respiratory tract congestion
Clinical narrative: cough, sore throat, cold sweats, congestion, shortness of breath due to coughing, headache, body aches, taste is off, smell is off, nausea, diarrhea.  starting 1/1/22
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Taste disorder
Clinical narrative: cough, sore throat, cold sweats, congestion, shortness of breath due to coughing, headache, body aches, taste is off, smell is off, nausea, diarrhea.  starting 1/1/22
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Angiogram pulmonary abnormal, Anion gap, Anticoagulant therapy
Clinical narrative: PAtient seen in ED and transferred for inpatient admission.  The patient is a 48-year-old gentleman was admitted to our service with concerns of hypoxia possibly related to COVID.  On presentation, the patient was noted to have persistent tachycardia and complaints of dizziness.  Given the patient's negative chest x-ray hypoxia and sinus tachycardia seemed out of proportion with his Infectious presentation.  CT of the chest was obtained given patient's history of significant PE.  CTA of the chest noted pulmonary embolism of significant size and portion including saddle pulmonary embolism with right heart strain.  A alert was sent out and the determination was made the patient will be best served to be transferred for ongoing workup and consideration of catheter directed therapy.Patient is a 48 y.o. male with h/o morbid obesity, essential HTN and PE s/p thrombectomy and IVC placement (Oct 2020)/removal (Feb 2021), transferring directly from Pennock Hospital where he was admitted on 1/2 with acute hypoxic respiratory failure initially thought secondary to COVID-19 pneumonia with later discovery of acute bilateral pulmonary embolism with saddle embolus.  He presented to the ER yesterday morning with c/o 1-week h/o dizziness in the setting of recent viral URI-type symptomatology.  These symptoms have included congestion, sinus drainage, sore throat, rhinorrhea, non-productive cough and dyspnea with exertion.  He was admitted here in Oct 2020 due to above noted prior PE and, following thrombectomy and IVC filter placement, he was discharged in stable condition on Coumadin for anticoagulation as his BMI limits other options.  It appears this anticoagulation was stopped in Jan 2021 in preparation for IVC filter retrieval in Feb 2021, and it was never restarted thereafter.  On arrival to the ER, he was found to be hypoxic and is now comfortable and maintaining appropriate SpO2 on 4L via NC.  He has been afebrile, normotensive, tachycardic and mildly tachypnic.  Initial labs suggest mild AKI with mild NAGMA, troponinemia with negative delta, elevated proBNP, elevated D-dimer, mild leukocytosis and positive COVID screen.  He was admitted to the hospitalist service at Pennock pre-CTA thorax and received COVID-directed dexamethasone and remdesivir.  Of note, aside from the large clot burden on CTA, the lungs appeared otherwise clear with no e/o pneumonia.  He was started on a heparin infusion and transfer was requested for possible repeat thrombectomy and Pulm consult here as noted by Dr.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriogram, COVID-19, COVID-19 pneumonia, Catheterisation cardiac, Central venous pressure increased
Clinical narrative: PAtient seen in ED and transferred for inpatient admission.  The patient is a 48-year-old gentleman was admitted to our service with concerns of hypoxia possibly related to COVID.  On presentation, the patient was noted to have persistent tachycardia and complaints of dizziness.  Given the patient's negative chest x-ray hypoxia and sinus tachycardia seemed out of proportion with his Infectious presentation.  CT of the chest was obtained given patient's history of significant PE.  CTA of the chest noted pulmonary embolism of significant size and portion including saddle pulmonary embolism with right heart strain.  A alert was sent out and the determination was made the patient will be best served to be transferred for ongoing workup and consideration of catheter directed therapy.Patient is a 48 y.o. male with h/o morbid obesity, essential HTN and PE s/p thrombectomy and IVC placement (Oct 2020)/removal (Feb 2021), transferring directly from Pennock Hospital where he was admitted on 1/2 with acute hypoxic respiratory failure initially thought secondary to COVID-19 pneumonia with later discovery of acute bilateral pulmonary embolism with saddle embolus.  He presented to the ER yesterday morning with c/o 1-week h/o dizziness in the setting of recent viral URI-type symptomatology.  These symptoms have included congestion, sinus drainage, sore throat, rhinorrhea, non-productive cough and dyspnea with exertion.  He was admitted here in Oct 2020 due to above noted prior PE and, following thrombectomy and IVC filter placement, he was discharged in stable condition on Coumadin for anticoagulation as his BMI limits other options.  It appears this anticoagulation was stopped in Jan 2021 in preparation for IVC filter retrieval in Feb 2021, and it was never restarted thereafter.  On arrival to the ER, he was found to be hypoxic and is now comfortable and maintaining appropriate SpO2 on 4L via NC.  He has been afebrile, normotensive, tachycardic and mildly tachypnic.  Initial labs suggest mild AKI with mild NAGMA, troponinemia with negative delta, elevated proBNP, elevated D-dimer, mild leukocytosis and positive COVID screen.  He was admitted to the hospitalist service at Pennock pre-CTA thorax and received COVID-directed dexamethasone and remdesivir.  Of note, aside from the large clot burden on CTA, the lungs appeared otherwise clear with no e/o pneumonia.  He was started on a heparin infusion and transfer was requested for possible repeat thrombectomy and Pulm consult here as noted by Dr.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray normal, Chest pain, Condition aggravated, Cough, Deep vein thrombosis
Clinical narrative: PAtient seen in ED and transferred for inpatient admission.  The patient is a 48-year-old gentleman was admitted to our service with concerns of hypoxia possibly related to COVID.  On presentation, the patient was noted to have persistent tachycardia and complaints of dizziness.  Given the patient's negative chest x-ray hypoxia and sinus tachycardia seemed out of proportion with his Infectious presentation.  CT of the chest was obtained given patient's history of significant PE.  CTA of the chest noted pulmonary embolism of significant size and portion including saddle pulmonary embolism with right heart strain.  A alert was sent out and the determination was made the patient will be best served to be transferred for ongoing workup and consideration of catheter directed therapy.Patient is a 48 y.o. male with h/o morbid obesity, essential HTN and PE s/p thrombectomy and IVC placement (Oct 2020)/removal (Feb 2021), transferring directly from Pennock Hospital where he was admitted on 1/2 with acute hypoxic respiratory failure initially thought secondary to COVID-19 pneumonia with later discovery of acute bilateral pulmonary embolism with saddle embolus.  He presented to the ER yesterday morning with c/o 1-week h/o dizziness in the setting of recent viral URI-type symptomatology.  These symptoms have included congestion, sinus drainage, sore throat, rhinorrhea, non-productive cough and dyspnea with exertion.  He was admitted here in Oct 2020 due to above noted prior PE and, following thrombectomy and IVC filter placement, he was discharged in stable condition on Coumadin for anticoagulation as his BMI limits other options.  It appears this anticoagulation was stopped in Jan 2021 in preparation for IVC filter retrieval in Feb 2021, and it was never restarted thereafter.  On arrival to the ER, he was found to be hypoxic and is now comfortable and maintaining appropriate SpO2 on 4L via NC.  He has been afebrile, normotensive, tachycardic and mildly tachypnic.  Initial labs suggest mild AKI with mild NAGMA, troponinemia with negative delta, elevated proBNP, elevated D-dimer, mild leukocytosis and positive COVID screen.  He was admitted to the hospitalist service at Pennock pre-CTA thorax and received COVID-directed dexamethasone and remdesivir.  Of note, aside from the large clot burden on CTA, the lungs appeared otherwise clear with no e/o pneumonia.  He was started on a heparin infusion and transfer was requested for possible repeat thrombectomy and Pulm consult here as noted by Dr.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea exertional, Echocardiogram abnormal, Ejection fraction, Ejection fraction normal
Clinical narrative: PAtient seen in ED and transferred for inpatient admission.  The patient is a 48-year-old gentleman was admitted to our service with concerns of hypoxia possibly related to COVID.  On presentation, the patient was noted to have persistent tachycardia and complaints of dizziness.  Given the patient's negative chest x-ray hypoxia and sinus tachycardia seemed out of proportion with his Infectious presentation.  CT of the chest was obtained given patient's history of significant PE.  CTA of the chest noted pulmonary embolism of significant size and portion including saddle pulmonary embolism with right heart strain.  A alert was sent out and the determination was made the patient will be best served to be transferred for ongoing workup and consideration of catheter directed therapy.Patient is a 48 y.o. male with h/o morbid obesity, essential HTN and PE s/p thrombectomy and IVC placement (Oct 2020)/removal (Feb 2021), transferring directly from Pennock Hospital where he was admitted on 1/2 with acute hypoxic respiratory failure initially thought secondary to COVID-19 pneumonia with later discovery of acute bilateral pulmonary embolism with saddle embolus.  He presented to the ER yesterday morning with c/o 1-week h/o dizziness in the setting of recent viral URI-type symptomatology.  These symptoms have included congestion, sinus drainage, sore throat, rhinorrhea, non-productive cough and dyspnea with exertion.  He was admitted here in Oct 2020 due to above noted prior PE and, following thrombectomy and IVC filter placement, he was discharged in stable condition on Coumadin for anticoagulation as his BMI limits other options.  It appears this anticoagulation was stopped in Jan 2021 in preparation for IVC filter retrieval in Feb 2021, and it was never restarted thereafter.  On arrival to the ER, he was found to be hypoxic and is now comfortable and maintaining appropriate SpO2 on 4L via NC.  He has been afebrile, normotensive, tachycardic and mildly tachypnic.  Initial labs suggest mild AKI with mild NAGMA, troponinemia with negative delta, elevated proBNP, elevated D-dimer, mild leukocytosis and positive COVID screen.  He was admitted to the hospitalist service at Pennock pre-CTA thorax and received COVID-directed dexamethasone and remdesivir.  Of note, aside from the large clot burden on CTA, the lungs appeared otherwise clear with no e/o pneumonia.  He was started on a heparin infusion and transfer was requested for possible repeat thrombectomy and Pulm consult here as noted by Dr.